CYP3A5 CONTRIBUTION TO BUDESONIDE TREATMENT FAILURE IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS.

被引：0
|
作者：
Chevalier, R. [1 ,2 ]
Shakhnovich, V. [1 ,2 ,3 ]
Gaedigk, R. [1 ]
Pirani, K. [1 ]
Noel-MacDonnell, J. [1 ]
机构：
[1] Childrens Mercy Kansas City, Kansas City, MO USA
[2] Univ Missouri, Kansas City, MO 64110 USA
[3] Ctr Childrens Hlth Lifestyles & Nutr, Kansas City, MO USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-047
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [31] Diagnosis and treatment of eosinophilic esophagitis in children
    Spergel, Jonathan M.
    Brown-Whitehorn, Terri A.
    Muir, Amanda
    Liacouras, Chris A.
    ALLERGY, 2020, 75 (06) : 1522 - 1524
  • [32] Dietary Treatment of Eosinophilic Esophagitis in Children
    Kagalwalla, Amir F.
    DIGESTIVE DISEASES, 2014, 32 (1-2) : 114 - 119
  • [33] Impact of CYP3A4, CYP3A5 and ABCB1 genotype and intestinal expression on the pharmacokinetics of budesonide
    Ufer, M.
    Dilger, K.
    Leschhorn, L.
    Daufresne, L. M.
    Mosyagin, I.
    Rosenstiel, P.
    Haesler, R.
    Nikolaus, S.
    Schreiber, S.
    Cascorbi, I.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 379 - 379
  • [34] Long-Term Treatment of Eosinophilic Esophagitis With Budesonide Oral Suspension
    Dellon, Evan S.
    Collins, Margaret H.
    Katzka, David A.
    Mukkada, Vincent A.
    Falk, Gary W.
    Morey, Robin
    Goodwin, Bridgett
    Eisner, Jessica D.
    Lan, Lan
    Desai, Nirav K.
    Williams, James
    Hirano, Ikuo
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (07) : 1488 - +
  • [35] Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence
    Miehlke, Stephan
    Lucendo, Alfredo J.
    Straumann, Alex
    Bredenoord, Albert Jan
    Attwood, Stephen
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [36] Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics
    Fröhlich, M
    Hoffmann, MM
    Burhenne, J
    Mikus, G
    Weiss, J
    Haefeli, WE
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (04) : 443 - 444
  • [37] Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis
    Fable, Jacqueline M.
    Fernandez, Marina
    Goodine, Susan
    Lerer, Trudy
    Sayej, Wael N.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (01): : 26 - 32
  • [38] USE OF THE CYP3A4 SELECTIVE INHIBITOR CYP3CIDE IN CYP3A5 GENOTYPED CRYOPRESERVED HUMAN HEPATOCYTES TO EXPLORE THE INDIVIDUAL CONTRIBUTION OF CYP3A4 AND CYP3A5 IN DRUG METABOLISM
    Heyward, Scott
    Schultz, Rachel N. V.
    Dennell, Stephen
    DRUG METABOLISM REVIEWS, 2014, 45 : 135 - 136
  • [39] Comparison of 2 Delivery Vehicles for Viscous Budesonide to Treat Eosinophilic Esophagitis in Children
    Rubinstein, Eitan
    Lee, John J.
    Fried, Ari
    Logvinenko, Tanya
    Ngo, Peter
    McDonald, Douglas
    Hait, Elizabeth J.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2014, 59 (03): : 317 - 320
  • [40] Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation
    McCune, JS
    Risler, LJ
    Phillips, BR
    Thummel, KE
    Blough, D
    Shen, DD
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (07) : 1074 - 1081
12345